HomeNDC LookupRxCUI directory › RxCUI 1999682

25 ML lutetium Lu 177 dotatate 10 MCI/ML Injection — RxCUI 1999682

RxNorm drug concept · Semantic clinical drug
RxCUI 1999682 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1999682
Official name25 ML lutetium Lu 177 dotatate 10 MCI/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslutetium Lu 177 dotatate 200 mCi per 25 ML Injection; lutetium Lu 177 dotatate 370 MBq/mL Injection; lutetium Lu 177 dotatate 7.4 GBq per 25 ML Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)33 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 25 ML lutetium Lu 177 dotatate 10 MCI/ML Injecti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 25 ML lutetium Lu 177 dotatate 10 MCI/ML Injection RxCUI 1999682

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dotatate 1797118
    • Lutetium Lu 177 dotatate 1999335
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lutathera 1999683
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dotatate Injection 2599510
    • Lutetium Lu 177 dotatate Injection 2648920
    • Dotatate Injectable Product 2599512
    • Lutetium Lu 177 dotatate Injectable Product 2659967
    • Dotatate Injection [Lutathera] 2599511
    • Lutetium Lu 177 dotatate Injection [Lutathera] 2655757
    • Lutathera Injectable Product 1999686
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lutetium Lu 177 dotatate 10 MCI/ML SCDC · 1999679
  • Dotatate Injection SCDF · 2599510
  • Lutetium Lu 177 dotatate Injection SCDFP · 2648920
  • Dotatate Injectable Product SCDG · 2599512
  • Lutetium Lu 177 dotatate Injectable Product SCDGP · 2659967

Brand-Name Concepts

  • 25 ML lutetium Lu 177 dotatate 10 MCI/ML Injection [Lutathera] SBD · 1999687
  • Lutetium Lu 177 dotatate 10 MCI/ML [Lutathera] SBDC · 1999684
  • Dotatate Injection [Lutathera] SBDF · 2599511
  • Lutetium Lu 177 dotatate Injection [Lutathera] SBDFP · 2655757
  • Lutathera Injectable Product SBDG · 1999686
  • Lutathera BN · 1999683

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1999682 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69488-0003-01 1 VIAL in 1 PACKAGE (69488-003-01) / 20.5 mL in 1 VIAL Lutathera Advanced Accelerator Applications USA, Inc 2018-01-26
Observed labelers: Advanced Accelerator Applications USA, Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.